MARKET

NUWE

NUWE

Nuwellis Inc
NASDAQ
3.870
+0.070
+1.84%
Opening 13:11 07/22 EDT
OPEN
3.783
PREV CLOSE
3.800
HIGH
3.900
LOW
3.783
VOLUME
11.88K
TURNOVER
0
52 WEEK HIGH
98.35
52 WEEK LOW
3.340
MARKET CAP
2.00M
P/E (TTM)
-0.4664
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NUWE last week (0715-0719)?
Weekly Report · 8h ago
Nuwellis reports first commercial sale of Quelimmune therapy to Cincinnati Children’s
Nuwellis reports first commercial sale of Quelimmune therapy to Cincinnati Children’s. Early clinical data suggest a 77% survival rate for patients treated with this new therapy. Nuwellis (NUWE) down -5.02% to $4.35.
Seeking Alpha · 5d ago
Nuwellis Achieves First QUELIMMUNE™ Sale, Cautions Investors
TipRanks · 5d ago
Nuwellis Marks First Commercial Sale Of QUELIMMUNE Therapy To Cincinnati Children's For Pediatric Patients Suffering From An Uncontrolled Inflammatory Response Triggered By Their Immune Systems
Nuwellis announces first commercial sale of QUELIMMUNE to Cincinnati Children's. The therapy is a novel therapy developed by SeaStar Medical Holding Corporation for pediatric patients suffering from an uncontrolled inflammatory response. Early clinical data suggest a 77% survival rate for patients treated with this new therapy.
Benzinga · 5d ago
NUWELLIS MARKS FIRST COMMERCIAL SALE OF QUELIMMUNE™ THERAPY TO CINCINNATI CHILDREN’S
Reuters · 5d ago
Weekly Report: what happened at NUWE last week (0708-0712)?
Weekly Report · 07/15 10:04
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Crown LNG stock is rocketing almost 154% after completing a business combination. Crown LNG is one of 10 top pre-market stock movers to watch on Friday morning. The biggest pre- market stocks to watch are mergers, clinical trial data, public offerings and more.
Investorplace · 07/12 11:41
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Mainz Biomed shares jumped 16% in today's pre-market trading. Pineapple Energy Inc. Shares rose 85% to $2.22 in pre- market trading. The company announced submission for the FDA Breakthrough Device Designation for its next generation CRC screening test.
Benzinga · 07/09 09:33
More
About NUWE
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Webull offers Nuwellis Inc stock information, including NASDAQ: NUWE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUWE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUWE stock methods without spending real money on the virtual paper trading platform.